These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 26314964)

  • 1. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
    Garg AD; Elsen S; Krysko DV; Vandenabeele P; de Witte P; Agostinis P
    Oncotarget; 2015 Sep; 6(29):26841-60. PubMed ID: 26314964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.
    Garg AD; Dudek AM; Ferreira GB; Verfaillie T; Vandenabeele P; Krysko DV; Mathieu C; Agostinis P
    Autophagy; 2013 Sep; 9(9):1292-307. PubMed ID: 23800749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Roles of Calreticulin in Cancer: Implications for Therapy.
    Venkateswaran K; Verma A; Bhatt AN; Shrivastava A; Manda K; Raj HG; Prasad A; Len C; Parmar VS; Dwarakanath BS
    Curr Protein Pept Sci; 2018 Feb; 19(4):344-357. PubMed ID: 28079009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphasic Increases of Cell Surface Calreticulin Following Treatment with Mitoxantrone.
    Azuma Y; Suzuki K; Higai K; Matsumoto K; Tada S
    Biol Pharm Bull; 2020 Oct; 43(10):1595-1599. PubMed ID: 32727970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
    Garg AD; Vandenberk L; Koks C; Verschuere T; Boon L; Van Gool SW; Agostinis P
    Sci Transl Med; 2016 Mar; 8(328):328ra27. PubMed ID: 26936504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models.
    Humeau J; Lévesque S; Kroemer G; Pol JG
    Methods Mol Biol; 2019; 1884():297-315. PubMed ID: 30465212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-Pulse Stimulation is a physical modality that can trigger immunogenic tumor cell death.
    Nuccitelli R; McDaniel A; Anand S; Cha J; Mallon Z; Berridge JC; Uecker D
    J Immunother Cancer; 2017; 5():32. PubMed ID: 28428881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecto-calreticulin in immunogenic chemotherapy.
    Obeid M; Tesniere A; Panaretakis T; Tufi R; Joza N; van Endert P; Ghiringhelli F; Apetoh L; Chaput N; Flament C; Ullrich E; de Botton S; Zitvogel L; Kroemer G
    Immunol Rev; 2007 Dec; 220():22-34. PubMed ID: 17979837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calreticulin-Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients.
    Kielbik M; Szulc-Kielbik I; Klink M
    Cells; 2021 Jan; 10(1):. PubMed ID: 33440842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death.
    Sun Y; Lu Z; Taylor JA; Au JLS
    J Control Release; 2024 Jan; 365():89-100. PubMed ID: 37981052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles in phagocytosis of the early and late increases of cell surface calreticulin induced by oxaliplatin.
    Matsusaka K; Azuma Y; Kaga Y; Uchida S; Takebayashi Y; Tsuyama T; Tada S
    Biochem Biophys Rep; 2022 Mar; 29():101222. PubMed ID: 35146135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining cisplatin with Pinellia pedatisecta Schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer.
    Wang C; Zhang M; Peng J; Zhang M; Lu C; Qi X; Luo Q; Wang Y; Li G
    Phytomedicine; 2024 Jun; 128():155504. PubMed ID: 38452404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria-targeted polyprodrug nanoparticles induce mitochondrial stress for immunogenic chemo-photodynamic therapy of ovarian cancer.
    Zhang W; Chen G; Chen Z; Yang X; Zhang B; Wang S; Li Z; Yang Y; Wu Y; Liu Z; Yu Z
    J Control Release; 2024 Jul; 371():470-483. PubMed ID: 38849094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Calreticulin-Targeting Monobodies to Detect Immunogenic Cell Death in Cancer Chemotherapy.
    Zhang Y; Thangam R; You SH; Sultonova RD; Venu A; Min JJ; Hong Y
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer.
    Flieswasser T; Van Loenhout J; Freire Boullosa L; Van den Eynde A; De Waele J; Van Audenaerde J; Lardon F; Smits E; Pauwels P; Jacobs J
    Cells; 2020 Jun; 9(6):. PubMed ID: 32560232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death.
    Panaretakis T; Joza N; Modjtahedi N; Tesniere A; Vitale I; Durchschlag M; Fimia GM; Kepp O; Piacentini M; Froehlich KU; van Endert P; Zitvogel L; Madeo F; Kroemer G
    Cell Death Differ; 2008 Sep; 15(9):1499-509. PubMed ID: 18464797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An "eat me" combinatory nano-formulation for systemic immunotherapy of solid tumors.
    Abdel-Bar HM; Walters AA; Lim Y; Rouatbi N; Qin Y; Gheidari F; Han S; Osman R; Wang JT; Al-Jamal KT
    Theranostics; 2021; 11(18):8738-8754. PubMed ID: 34522209
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.
    Sukkurwala AQ; Martins I; Wang Y; Schlemmer F; Ruckenstuhl C; Durchschlag M; Michaud M; Senovilla L; Sistigu A; Ma Y; Vacchelli E; Sulpice E; Gidrol X; Zitvogel L; Madeo F; Galluzzi L; Kepp O; Kroemer G
    Cell Death Differ; 2014 Jan; 21(1):59-68. PubMed ID: 23787997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
    Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
    Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner.
    Yang PM; Hsieh YY; Du JL; Yen SC; Hung CF
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.